St. Jude Children's Research Hospital Licenses MetaCore From GeneGo
News Feb 02, 2007
GeneGo, Inc., has announced that St. Jude Children's Research Hospital has licensed its data mining suite MetaCore.
The latest version MetaCore 4.2 includes a GeneGo ontology of cellular process networks, which goes a step beyond GO ontology which is also available in MetaCore.
It contains additional functional processes and more genes have been networked using GeneGo proprietary network algorithms.
MetaCore has an in depth knowledge base for pediatric cancer and the unique ability to concurrently visualize gene expression and proteomics data.
MetaCore also covers many species including human, mouse, rat, chicken, dog, worm, yeast and chimpanzee. MetaCore spans research, discovery and clinical trials.
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research. A team of scientists used genome sequencing technology to identify which genes make MRSA susceptible to a previously defined combination of drugs. They identified a number of mutations centered around a protein known as a penicillin-binding protein 2a or PBP2a.